SEC Company Response from Scorpius Holdings, Inc. (SCPX) (CIK 0001476963) (SCPX) — May 1, 2020
Scorpius Holdings, Inc. (SCPX) (CIK 0001476963)
Date: May 1, 2020 · CIK: 0001476963 · Accession: 0001553350-20-000383
AI Filing Summary & Sentiment
File numbers found in text: 333-237808
Letter
VIA EDGAR Division of Corporation Finance Attention: Courtney Lindsay Re: Heat Biologics, Inc. Registration Statement on Form S-3 File No. 333-237808
Dear Ms. Lindsay:
Heat Biologics, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-237808) be accelerated by the U.S. Securities and Exchange Commission to Monday, May 4, 2020 at 4:00 pm, New York City Time, or as soon as reasonably practicable thereafter.
The Company hereby authorizes Leslie Marlow and Patrick Egan of Gracin & Marlow, LLP to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (516) 496-2223 or (212) 907-6457, or Mr. Egan at (914) 557-5574 with any questions you may have concerning this request, and please notify either of them when this request for acceleration has been granted.
Very truly yours,
Heat Biologics, Inc.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request Heat Biologics, Inc. 627 Davis Drive, Suite 400 Morrisville, North Carolina 27560 May 1, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Courtney Lindsay Re: Heat Biologics, Inc. Registration Statement on Form S-3 File No. 333-237808 Dear Ms. Lindsay: Heat Biologics, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-237808) be accelerated by the U.S. Securities and Exchange Commission to Monday, May 4, 2020 at 4:00 pm, New York City Time, or as soon as reasonably practicable thereafter. The Company hereby authorizes Leslie Marlow and Patrick Egan of Gracin & Marlow, LLP to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (516) 496-2223 or (212) 907-6457, or Mr. Egan at (914) 557-5574 with any questions you may have concerning this request, and please notify either of them when this request for acceleration has been granted. Very truly yours, Heat Biologics, Inc. By: /s/ Jeffrey Wolf Name: Jeffrey Wolf Title: Chief Executive Officer